Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals
Portfolio Pulse from Benzinga Insights
Investors have taken a bearish stance on Vertex Pharmaceuticals (NASDAQ:VRTX) based on recent options trading data. Benzinga's options scanner identified 8 transactions, with 75% being bearish. Analysts have mixed ratings, with price targets ranging from $376 to $600.
August 09, 2024 | 6:45 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Recent options trading data shows a bearish sentiment on Vertex Pharmaceuticals, with 75% of the trades being bearish. Analysts have mixed ratings, with price targets ranging from $376 to $600.
The significant bearish sentiment in options trading suggests that investors are expecting a decline in VRTX's stock price. This is further supported by mixed analyst ratings, with some setting lower price targets.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100